Pharma Seeks Digital Innovators: A New Phase of the “Pharma Digital Hype Cycle”

The pharmaceutical industry has often been criticized for being behind the "digital curve," meaning that it lacks the expertise to fully take advantage of...

#Pharma100: A Ludicrous, Leveraged Popularity Contest

"Stop using #pharma100," says Andrew Spong. Spong says it's "a ludicrous popularity contest... that degrades the health conversation on the Social Web." Quite a...

AZPurpleZone: A Nexium Branded YouTube Channel. “Unusual” for Pharma? Yes. “Engaging Social Media?” No!

"AstraZeneca believes that it is important to share information with patients by engaging with them online," says Ken Graham, Commercial Business Leader, GI, AstraZeneca,...

The MeltDown of Paula Deen Continues

Just when you thought the latest Paula Deen news cycle is over, up pops a new article about the celebrity chef's fall from grace. For...

FDA is Lax in Enforcing Law Regarding Prescription Drug Postmarketing Studies

The Food and Drug Administration Amendments Act (FDAAA), passed by Congress in 2007, authorized the FDA to require postmarketing studies for a prescription drug’s...

EU Pharma Industry May Ban “Tchotchkes” Outright! Tchotchke Makers Threaten to Sue.

According to the Financial Times (here), the European Promotional Product Association (EPPA), a trade body representing "tchotchke" makers, is threatening to sue the EU...

Graduation Day at Roche Digital Academy: What’s Next?

The Roche Digital Academy concluded with a Graduation day on July 1. This training program, developed by the Digital Team Roche Italy, in...

Pharma Marketing News Vol. 12, No. 6: 31 July 2013

Welcome to Volume 12, Issue #6 (31 July 2013) of Pharma Marketing News.

Seen on Vine: Loopy 6-Second Pharma Videos

Have you heard of or used "Vine" yet? Vine is a new app from Twitter that allows users to record six-second videos that playback in...

Lack Sexual Desire? Try, Try Again!

Boehringer gave up on flibanserin -- so-called "Female Viagra" -- after the FDA refused to approve it for female sexual arousal disorder, also known...